CLEVELAND, Ohio — When the Los Angeles Angels announced Kurt Suzuki as their new manager this week, it wasn’t just another hiring – it was the latest evidence that baseball’s traditional managerial ...

DEAR ABBY: I’m 22, and my boyfriend is 21. We’ve been dating for a few months. At a recent family dinner, his maternal grandfather hit on me. I was helping to clear the dinner table and leaned across ...

NFL analyst Tony Rizzo isn’t a fan of Cleveland Browns star pass rusher Myles Garrett after his recent comments. The Browns suffered a 23-9 loss to the Pittsburgh Steelers on the road in Week 6.

According to Rivals' Hayes Fawcett, recent Alabama Crimson Tide commit Jared Doughty has reportedly shut down his recruitment. A member of Alabama's 2026 class, Doughty previously announced his ...

Amiral Gestion increased its Adobe stake, bringing the position to 15.91% of 13F AUM, the fund’s largest holding as of Sept. 30, 2025. Top holdings after the filing: NASDAQ:ADBE: $43.78 million (15.9% ...

Prince Harry is facing fresh criticism after his unannounced appearance at the Burma Star Memorial on VJ Day was branded a calculated “PR stunt” by palace insiders. The Duke of Sussex placed a ...

Shares of Robinhood Markets Inc (NASDAQ:HOOD) are taking a breather Monday morning as investors digest the stock’s recent rise to all-time highs. Here’s what investors need to know. What To Know: The ...

T. Rowe Price Group has some great stockpickers at its funds. But owning shares of T. Rowe itself wouldn’t have done them any favors. While the S&P 500 index has more than doubled over the past five ...

Shedeur Sanders made headlines this week by not saying anything during a recent interview. Sanders’ NFL team, the Cleveland Browns, made a quarterback change by demoting the starter, veteran Joe ...

Bloom Energy (NYSE:BE) -0.3% in Thursday's trading as Mizuho downgraded shares to Neutral from Outperform but raised its DCF-based price target to $79 from $48, citing improved visibility for the ...

High-rolling investors have positioned themselves bearish on CRISPR Therapeutics (NASDAQ:CRSP), and it's important for retail traders to take note. \This activity came to our attention today through ...